Literature DB >> 15509555

p53 suppresses c-Myb-induced trans-activation and transformation by recruiting the corepressor mSin3A.

Jun Tanikawa1, Teruaki Nomura, Elizabeth M Macmillan, Toshie Shinagawa, Wanzhu Jin, Kenji Kokura, Daichi Baba, Masahiro Shirakawa, Thomas J Gonda, Shunsuke Ishii.   

Abstract

p53 is known to repress transcription of a number of genes, but the mechanism of p53 recruitment to these target genes is unknown. The c-myb proto-oncogene product (c-Myb) positively regulates proliferation of immature hematopoietic cells, whereas p53 blocks cell cycle progression. Here, we demonstrate that p53 inhibits c-Myb-induced transcription and transformation by directly binding to c-Myb. The ability of c-Myb to maintain the undifferentiated state of M1 cells was also suppressed by p53. p53 did not affect the ability of c-Myb to bind to DNA but formed a ternary complex with the corepressor mSin3A and c-Myb. Thus, p53 antagonizes c-Myb by recruiting mSin3A to down-regulate specific Myb target genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509555     DOI: 10.1074/jbc.M411658200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  A novel mammalian complex containing Sin3B mitigates histone acetylation and RNA polymerase II progression within transcribed loci.

Authors:  Petar Jelinic; Jessica Pellegrino; Gregory David
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

2.  Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.

Authors:  Chad Deisenroth; Aaron R Thorner; Takeharu Enomoto; Charles M Perou; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

3.  Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.

Authors:  Guo-shun Shu; Fang Lv; Zhu-lin Yang; Xiong-ying Miao
Journal:  Int J Clin Oncol       Date:  2012-06-21       Impact factor: 3.402

4.  The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.

Authors:  Toshihiro Kurahashi; Teruaki Nomura; Chie Kanei-Ishii; Yoichi Shinkai; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-07-29       Impact factor: 4.138

5.  Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.

Authors:  Chul Won Lee; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

6.  Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein-regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1.

Authors:  Liheng Shi; Soyoung Ko; Soyoung Kim; Ibtissam Echchgadda; Tae-Sung Oh; Chung S Song; Bandana Chatterjee
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

7.  p53 gain-of-function mutations increase Cdc7-dependent replication initiation.

Authors:  Arindam Datta; Dishari Ghatak; Sumit Das; Taraswi Banerjee; Anindita Paul; Ramesh Butti; Mahadeo Gorain; Sangeeta Ghuwalewala; Anirban Roychowdhury; Sk Kayum Alam; Pijush Das; Raghunath Chatterjee; Maitrayee Dasgupta; Chinmay Kumar Panda; Gopal C Kundu; Susanta Roychoudhury
Journal:  EMBO Rep       Date:  2017-09-08       Impact factor: 8.807

8.  A distal mutation perturbs dynamic amino acid networks in dihydrofolate reductase.

Authors:  David D Boehr; Jason R Schnell; Dan McElheny; Sung-Hun Bae; Brendan M Duggan; Stephen J Benkovic; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2013-06-24       Impact factor: 3.162

9.  c-Myb Binding Sites in Haematopoietic Chromatin Landscapes.

Authors:  Mads Bengtsen; Kjetil Klepper; Sveinung Gundersen; Ignacio Cuervo; Finn Drabløs; Eivind Hovig; Geir Kjetil Sandve; Odd Stokke Gabrielsen; Ragnhild Eskeland
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

10.  A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity.

Authors:  Maria Yusenko; Anke Jakobs; Karl-Heinz Klempnauer
Journal:  Sci Rep       Date:  2018-09-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.